NFWClass II
Test, Cannabinoid, Over The Counter
21 CFR 862.3870 / Clinical Toxicology
NFW is the FDA product code for Test, Cannabinoid, Over The Counter, a class II device type, regulated under 21 CFR 862.3870. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- NFW
- Device name
- Test, Cannabinoid, Over The Counter
- Regulation
- 21 CFR 862.3870
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code NFW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2019 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Applicants with the most clearances
Product code NFW| Applicant | Clearances |
|---|---|
| Healgen Scientific LLC | 1 |
| Safecare Biotech(hangzhou)co.,Ltd | 1 |
| Shenzhen Bioeasy Biotechnology Co., Ltd. | 1 |
| Vivachek Biotech (Hangzhou) Co., Ltd | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- 2SAN LLC
- ABOUND Diagnostics, Inc
- Aceso Laboratories Inc.
- ACRO BIOTECH Inc.
- Advin Biotech, Inc.
- Alfa Scientific Designs, Inc.
- American Screening Corporation
- Analysis Oasis Global LLC
- Anhui Deepblue Medical Technology Co., Ltd.
- Assure Tech LLC
- Assure Tech. (Hangzhou) Co., Ltd.
- Bioteke Corporation (Wuxi) Co., Ltd
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
